SC
HAE icon

Skylands Capital’s Haemonetics HAE Stock Holding History

Skylands Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
47,625
-18,200
-28% -$1.17M 0.44% 59
2026
Q1 		$3.71M Buy
65,825
+29,350
+80% +$1.91M 0.49% 60
2025
Q4 		$2.92M Sell
36,475
-44,894
-55% -$3.02M 0.4% 71
2025
Q3 		$3.97M Buy
81,369
+53,819
+195% +$3.33M 0.55% 54
2025
Q2 		$2.06M Sell
27,550
-28,225
-51% -$1.87M 0.3% 75
2025
Q1 		$3.54M Buy
55,775
+28,600
+105% +$1.95M 0.51% 57
2024
Q4 		$2.12M Buy
27,175
+3,875
+17% +$311K 0.3% 75
2024
Q3 		$1.87M Buy
+23,300
New +$1.88M 0.25% 80

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Skylands Capital's HAE Position: Q2 2026 in Review

Skylands Capital reduced its Haemonetics (HAE) stake by 28% in Q2 2026, selling an estimated $1.17M and leaving 47,625 shares worth $3.57M. The position accounts for 0.44% of the portfolio, ranked #59.

Skylands Capital first reported a position in HAE in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.97M in Q3 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Skylands Capital held 47,625 shares of Haemonetics worth $3.57M as of Q2 2026.
  • Skylands Capital sold 18,200 Haemonetics shares in Q2 2026, an estimated $1.17M.
  • Haemonetics made up 0.44% of Skylands Capital's portfolio in Q2 2026, its #59 holding.
  • Skylands Capital first reported a position in Haemonetics in Q3 2024 and has held it in 8 quarters since.
  • Skylands Capital's Haemonetics position peaked at $3.97M in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Skylands Capital's 13F filing for Q2 2026, filed 24 Jul 2026.